New Data Show PillCam(R) SB to Be an Accurate Tool to Evaluate Patients With Crohn's Disease, Functional GI Disorders ...
BARCELONA, SPAIN--(Marketwire - 10/25/10) - Given Imaging Ltd. (NASDAQ: GIVN - News ) today announced several new studies that demonstrate PillCam SB's clinical value in detecting and monitoring Crohn's disease and its utility in managing patients with obscure GI bleeding (OGIB). The studies were presented at the United European Gastroenterology Week (UEGW) 2010
No comments:
Post a Comment